{"transactions":[{"id":1016940,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-17T22:37:52.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's service to the issuer continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the issuer's incentive plan (the \"Plan\") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full upon the occurrence of a Change in Control, as defined in the Plan."}],"balance_after":215000,"derivative":{"exercise_price":1.92,"expiration_date":"2035-10-15","underlying":"Common Stock, par value $0.01 per share","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001710496-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000171049625000002/primary_doc.xml","form_type":"4"}},{"id":1140628,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-05-20T20:56:19.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":347279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Forty percent (40%) of the options vested immediately upon grant, and the remainder will vest in three equal annual installments beginning on 05/16/2026. The reporting person has agreed not to sell any shares underlying the options, even if exercised, for a period of three years from the date of grant."}],"balance_after":347279,"derivative":{"exercise_price":1.81,"expiration_date":"2035-05-16","underlying":"Common Stock, par value $0.01 per share","underlying_shares":347279},"source":{"system":"sec-edgar","filing":"0001474506-25-000099","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000147450625000099/primary_doc.xml","form_type":"4"}},{"id":1140627,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2025-05-20T20:56:19.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001474506-25-000099","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000147450625000099/primary_doc.xml","form_type":"4"}},{"id":1676033,"issuer":{"id":8618,"kind":"organization","name":"Odyssey Health, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T17:10:09.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0.085,"value":3187.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024."}],"balance_after":37500,"derivative":{"exercise_price":0.085,"exercise_date":"2024-01-16","expiration_date":"2034-01-15","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001683168-24-000340","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316824000340/ownership.xml","form_type":"4"}},{"id":1696051,"issuer":{"id":8618,"kind":"organization","name":"Odyssey Health, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-02T17:10:18.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.1,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023"}],"balance_after":200000,"derivative":{"exercise_price":0.1,"exercise_date":"2023-12-29","expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001683168-24-000026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316824000026/ownership.xml","form_type":"4"}},{"id":2104885,"issuer":{"id":8618,"kind":"organization","name":"Odyssey Health, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chief Commercial Officer"}}],"security":"Stock Option - Right to buy","published_at":"2022-11-23T16:02:53.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":475000,"price":0.25,"value":118750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."}],"balance_after":0,"derivative":{"exercise_price":0.25,"expiration_date":"2032-10-31","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001683168-22-008022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822008022/ownership.xml","form_type":"4"}},{"id":2104884,"issuer":{"id":8618,"kind":"organization","name":"Odyssey Health, Inc."},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chief Commercial Officer"}}],"security":"Stock Option - Right to buy","published_at":"2022-11-23T16:02:53.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":125000,"price":0.25,"value":31250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE."}],"balance_after":125000,"derivative":{"exercise_price":0.25,"exercise_date":"2022-11-01","expiration_date":"2032-10-31","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001683168-22-008022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822008022/ownership.xml","form_type":"4"}},{"id":3868994,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":74173,"kind":"person","name":"Emerson Erik C.","position":1,"cik":"0001710496","reported_name":"Emerson Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2018-07-12T17:00:23.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":1125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 187,500 shares of common stock are exercisable immediately, options to purchase 187,500 shares of common stock are exercisable on each of July 10, 2019, July 10, 2020 and July 10, 2021, options to purchase 187,500 shares of common stock shall vest on such date, if any, as the Issuer determines that it has achieved net product revenue in the amount of not less than $1.2 million for the portion of the 2018 fiscal year following June 18, 2018, and options to purchase 187,500 shares of common stock shall vest on such date, if any, as the Issuer determines that the daily VWAP of the common stock of the Issuer was not less than $2.00 per share for a sixty consecutive day period beginning on any calendar day during the 2018 fiscal year on or after June 18, 2018."}],"balance_after":1125000,"derivative":{"exercise_price":0.66,"expiration_date":"2028-07-10","underlying":"common stock","underlying_shares":1125000},"source":{"system":"sec-edgar","filing":"0001493152-18-009946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218009946/ownership.xml","form_type":"4"}}]}